Styrene-butadiene rubber (SBR), a copolymer of styrene and 1,3-butadiene, is the most widely used synthetic rubber in the world. The U.S. government foresaw shortages of natural rubber as a result of the growing demands during World War II and financed construction offifteen SBR plants, two butyl rubber plants, sixteen 1,3-butadiene production facilities and five styrene plants. Between 1946 and 1955 these plants were sold to various private companies. In 1984, the 1,3-butadiene consumption in the U.S. was estimated to be about 3.24 billion pounds per year with at least 3 billion being used to make synthetic rubber (1) . In the National Institute for Occupational Safety and Health (NIOSH) Criteria Document on Styrene, it was estimated that the U.S. production of styrene in 1981 was 6.61 billion pounds per year, with approximately 0.44 billion pounds being used to manufacture SBR (2) . The number of workers employed in rubber and plastic production was estimated to be a little over 9,000 (1) . The exact number of workers employed in SBR production is unknown. Primarily, styrene is produced by de- hydrogenating ethyl benzene, the reaction product of benzene plus ethylene. A small portion is made from ethylbenzene that is recovered directly from refinery streams (3) .
In January 1976, two men who had been employed at adjacent SBR production facilities in Port Neches, TX, Styrene and 1,3-butadiene were considered the target chemicals for the investigation; however, benzene exposure was also evaluated because of its known association with leukemia. Air samples were taken in both plants from all areas and were found to be well within the existing Occupational Safety and Health Administration (OSHA) PELs (100 ppm styrene, 1000 ppm butadiene, and 10 ppm benzene). Anecdotal information from discussions with plant A management personnel indicated that benzene was not nor had ever been directly used in the production of SBR; therefore the observed concentrations might be explained by chance, general environmental leaks, and styrene impurities.
The retrospective mortality portion of the investigation began on January 1, 1943 The findings of this study provided limited support for the suggestion that the production or manufacture of SBR might be associated with an excess of lymphatic and hematopoietic neoplasms, and continued follow-up of these cohorts seemed warranted. In summary, no statistically significant excesses in cause-specific mortality were found in the overall populations at plant A, plant B, or the restricted plant A, based on an evaluation using a two-sided statistical test. There was a nonstatistically significant excess for neoplasms of the lymphatic and hematopoietic tissues found in the overall plant A population and the restricted plant A population.
Since the completion ofthe Meinhardt et al. report (5) , two animal inhalation bioassays have found 1,3-butadiene to be carcinogenic in rats (10) and in mice (11) . Additionally, the findings of McMichael et al. (4) prompted a more detailed case-referent study of these cancer deaths by Spirtas et al. (12) ; this evaluation revealed an estimated relative risk of 2.4 for fatal lymphatic and hematopoietic malignancies associated with employment in the SBR production plant. Monson and Nakano (13) , examined the mortality rates of all members of the same local union working for one rubber company in Akron, Ohio. The study included 13,571 men who had worked during or after 1935 for at least 5 years. Excesses of leukemia deaths were observed for those men working in the tire and the processing divisions with SMRs of 150 and 240, respectively. The processing department included synthetic rubber production. These results reinforce the possibility of an association between exposure to SBR production and the development of lymphatic and hematopoietic malignancies.
Matanoski et al. (14) found no significant excesses in cause-specific mortality in a study consisting of small numbers of workers in the cohorts from 8 facilities, which had relatively short latency periods among workers thought to be exposed to SBR. The Meinhardt et al.(5) . These authors compared the mortality patterns of the worker cohort with both national U.S. mortality and with local mortality patterns. As in the Meinhardt et al. report (5) , the overall total mortality was less than expected, with an SMR of 80 (p < 0.05) for the comparison with the U.S. mortality. For the all-cancer category the SMR was 84. and corresponding comparisons with the local mortality rates resulted in SMRs of 96 for total mortality and 76 (p < 0.05) for all cancer. The only significant excess of death observed for those in the routinely exposed group was for lymphosarcoma and reticulum cell sarcoma with an SMR of235 (8 observed versus 3.4 expected, p < 0.05) when compared with the national U.S. rates. Strokes were significantly increased in the nonroutinely exposed group when compared with the local mortality rates only. The authors emphasized the shortcomings of the study to be (a) unreliable race designations, (b) lack of work histories and industrial hygiene data, (c) an employment period ofless than 5 years for almost half ofthe total cohort, (d) the possibility that the cohort was incomplete, and a comparatively small sample size. On the positive side, the authors point out that the study involved one of the largest cohorts studied to date. They also affirmed that the power of the study was adequate to detect a doubling ofrisks for many causes of death and was sufficient to detect a tripling of risk for most causes.
In conclusion, the authors evaluated the role of 1,3-butadiene in the excess deaths noted and felt that further follow-up and additional studies need careful attention.
The findings from each of the previously outlined studies show similar observations of deaths. However, they do not provide sufficient insight into the risks posed to workers in the SBR production industry.
Currently the follow-up to the Meinhardt et al. study (5) The continued analysis of the mortality occurring to SBR production workers may never provide definitive answers about the health effects associated with either styrene or 1,3-butadiene because of the diffuse and poorly defined nature of exposure in this industry. At the present time, it is not clear from this study whether a real leukemogenic risk is associated with SBR production or whether the reported excesses in lymphatic and hematopoietic malignancies are artifacts in the populations studied. However, since there are continuing reports of additional cancers occurring to individuals exposed to this industrial process and since the evaluation of a mixed chemical exposure environment with very low levels of exposure may provide evidence of health risks not detected in single-agent evaluations, the continued evaluation of workers in this industry seems warranted.
